Dr. Michael Morris is a world-renowned medical oncologist and section head of Memorial Sloan Kettering’s GU Oncology department. In this hour long webinar, sponsored by the National Alliance of State Prostate Cancer Coalitions, Dr. Morris clearly explains the great advance in scanning technology that PSMA PET imaging represents. He compares it to other scanning technologies in a way that will finally make sense to you. He states that he expects PSMA agents to be approved by the FDA for the detection of prostate cancer recurrences before the end of this year.
When you click on the link, you may be required to register yourself in order to view the webinar. This simply requires you to enter your name and email address. Enjoy and be informed!